Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism

The burden of obesity and associated cardiometabolic diseases has been considered as an important risk factor for lupus patients. Therefore, whether obesity is involved in the over-activation of autoimmune response has attracted more and more attention. Hydroxychloroquine is a synthetic antimalarial...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Pharmacol
Hoofdauteurs: Qiao, Xin, Zhou, Zhuo-Chao, Niu, Rui, Su, Yu-Tong, Sun, Yue, Liu, Hong-Lei, Teng, Jia-Lin, Ye, Jun-Na, Shi, Hui, Yang, Cheng-De, Cheng, Xiao-Bing
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2019
Onderwerpen:
Pharmacology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6689966/
https://ncbi.nlm.nih.gov/pubmed/31427967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00855
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items